TLRY - These 2 Robinhood Stocks Are Down Around 15% This Month: Should You Buy the Dip?
There's often a lot of hype surrounding Robinhood stocks, and sometimes that can help carry share prices to astronomical heights. But that isn't happening of late with two of the platform's more popular holdings, Facebook (NASDAQ: FB) and Tilray (NASDAQ: TLRY) .
Since the start of September, both stocks are down by about 15% and doing much worse than the S&P 500 , which has declined by just 7% during the same period. But are these top Robinhood stocks in trouble, or is now the time to scoop up these deals before their share prices rally? Let's take a closer look at the businesses and find out.
Tilray's stock is down 26% in September, and yet the company hasn't released any news since it reported its second-quarter results on Aug. 10. One of the problems with investing in pot stocks is that industrywide problems or concerns can often send stocks reeling. The Horizons Marijuana Life Sciences ETF (OTC: HMLSF) is down 13% this month, a more modest decline than Tilray's. What's surprising is that the British Columbia-based company is coming off a decent quarter during which it reported sales of $50.4 million for the period ending June 30. That's up 10% from the previous year. And while it may not be a huge increase, some cannabis companies struggle to generate any top-line growth whatsoever .
For further details see:
These 2 Robinhood Stocks Are Down Around 15% This Month: Should You Buy the Dip?